People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DalCor Pharmaceuticals US, LLC | — | Pharmaceuticals | Series B | $20.4M | $131.0M | 2016 |
Laurence Michael Rulleau at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Laurence Michael Rulleau on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Fonteyne | 1 | 5 |
| Robert McNeil | 1 | 3 |
| D. Michael Dixon | 1 | 2 |
| Mark Michael Smith | 1 | 2 |
| Didier Michael Leconte | 1 | 1 |
| Donald Black | 1 | 1 |
| Ga?tan Michael Gravel | 1 | 1 |
| Louise Michael Proulx | 1 | 1 |
| Thomas Michael Birch | 1 | 1 |
| Rody Michael Yared | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.